Daiichi Sankyo announced that its Phase III ENLIVEN trial of pexidartinib met its primary endpoint. Source: BioSpace

The money is intended to to fuel European biotech startups. Source: BioSpace

Anders Gotzsche will serve as interim CEO while the company looks for a replacement for Kare Schultz who leaves the company Oct. 31 for the CEO position at Teva. Source:…

The two companies will jointly develop Imeglimin for the treatment of type 2 diabetes in Japan. Source: BioSpace

Late on Friday, Merck announced that it had pulled its application for Keytruda in combination with pemetrexed and carboplatin as a first-line treatment for metastatic nonsquamous NSCLC from the EMA.…

Kymera Therapeutics launched with a $30M Series A financing which was lead by Atlas Venture. Source: BioSpace

As part of consolidation program, Shire is looking to sell a manufacturing facility in Milford, MA that it gained through its 2015 acquisition of Baxalta. Source: BioSpace

Want to work for a company having a growth spurt? Source: BioSpace

Insys continues to receive an optics beating in the wake of the charges against company founder John Kapoor and multiple executives surrounding illegal sales practices of its cancer pain drug.…

Amazon, as most everyone knows, has its fingers in a lot of pies. Source: BioSpace